Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial

Martin Reck, Igor Bondarenko, Alexander Valerievich Luft et al. · Annals of Oncology · 2012

Cited by 611 works. doi:10.1093/annonc/mds213 Open-access PDF

Authors

References